| Literature DB >> 21595935 |
Sébastien Hulo1, Hélène Tiesset, Steve Lancel, Jean Louis Edmé, Benoit Viollet, Annie Sobaszek, Rémi Nevière.
Abstract
BACKGROUND: Acute ozone exposure causes lung oxidative stress and inflammation leading to lung injury. At least one mechanism underlying the lung toxicity of ozone involves excessive production of reactive oxygen and nitrogen intermediates such as peroxynitrite. In addition and beyond its major prooxidant properties, peroxynitrite may nitrate tyrosine residues altering phosphorylation of many protein kinases involved in cell signalling. It was recently proposed that peroxynitrite activates 5'-AMP-activated kinase (AMPK), which regulates metabolic pathways and the response to cell stress. AMPK activation as a consequence of ozone exposure has not been previously evaluated. First, we tested whether acute ozone exposure in mice would impair alveolar fluid clearance, increase lung tissue peroxynitrite production and activate AMPK. Second, we tested whether loss of AMP-activated protein kinase alpha1 subunit in mouse would prevent enhanced oxidative stress and lung injury induced by ozone exposure.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21595935 PMCID: PMC3120668 DOI: 10.1186/1465-9921-12-64
Source DB: PubMed Journal: Respir Res ISSN: 1465-9921
Figure 1Effects of ozone exposure on lung inflammation in control mice. Total protein concentration (A), total cell count and neutrophil count (% × 1 000) (B) in BAL fluid and pro-inflammatory cytokine levels (C) in lung homogenates were measured as markers of pulmonary inflammation. Ozone-exposed groups were exposed to air containing 2 ppm ozone continuously for 3 h. Parameters were evaluated 24 h after exposure. Data are presented as means ± SD. *p < 0.05, when compared with non-exposed mice (n = 10 in control group and n = 8 in ozone-exposed group). BAL: bronchoalveolar lavage; TNF-α: tumor necrosis factor alpha; IL1β: interleukin 1 beta; IL6: interleukin 6
MDA levels, MPO activity and peroxynitrite levels in lung homogenates WT or AMPKα1 deficient mice
| control mice | AMPKα1 deficient mice | ||||
|---|---|---|---|---|---|
| Air | Ozone | Air | Ozone | ||
| MDA (μmol/g wet tissue) | 110 +/- 14.1* | 230 +/- 10* | 160 +/- 13 | 147 +/- 12.6 | *p < 0.0001 |
| MPO (U/g wet tissue) | 0.13 +/- 0.03* | 0.27 +/- 0.04* | 0.13 +/- 0.02 | 0.16 +/- 0.06 | *p = 0.04 |
| Peroxynitrite (nmol/L) | 3.0 +/- 0.2* | 4.4 +/- 1.0* | 2.8 +/- 0.5 | 2.8 +/- 0.4 | *p = 0.03 |
Mice were exposed to air with or without ozone at 2 ppm for 3 h. Parameters were evaluated 24 h after exposure. Malondialdehyde (MDA) was expressed as micromole per g weight of wet tissue; Myeloperoxidase activity (MPO) was expressed in units per gram weight of wet tissue. Peroxynitrite was expressed as nmol/L. Data are presented as means ± SD. *: p < 0.05; μmol/g wet tissue: micromole per g weight of wet tissue; U/g wet tissue: units per gram weight of wet tissue
Figure 2P(Thr172)-AMPK to total AMPK ratio in control mice lung homogenates. P(Thr172)-AMPK to total AMPK ratio (A) and Western Blot analysis (B) were performed in control mice lung homogenates. Mice were exposed or not to ozone at 2 ppm for 3 h. Parameters were evaluated 24 h after exposure. Data are presented as means ± SD. *: p < 0.05; (n = 6 in each group). AMPK: adenosine monophosphate activated protein kinase
Figure 3Alveolar fluid clearance and basolateral membrane Na,K-ATPase abundance in WT or AMPKα1 deficient mice. (A) Alveolar fluid clearance (%) in wild type or AMPKα1 deficient mice exposed (n = 3) or not (n = 4) to ozone at 2 ppm for 3 h. (B) Western Blot analysis of Na,K-ATPase expression at the plasma membrane in wild type or AMPKα1 deficient mice exposed (n = 3) or not (n = 4) to ozone at 2 ppm for 3 h. The amount of Na,K-ATPase was normalized to GLUT1. Results were expressed in fold increased of control. Mice were exposed to air with or without ozone at 2 ppm for 3 h. Parameters were evaluated 24 h after exposure; *: p < 0.05; GLUT1: glucose transporter 1.